LTBP-2 competes with tropoelastin for binding to fibulin-5 and heparin, and is a negative modulator of elastinogenesis

Matrix Biology

Volumn 34, Issue , 2014, Pages 114-123

  Sideek, Mohamed A ^a   Menz, Clementine ^a   Parsi, Mahroo K ^a   Gibson, Mark A ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Fibulin 5; Heparan sulfate; Heparin; LTBP 2; Tropoelastin

Indexed keywords

FIBRILLIN 1; FIBULIN 5; HEPARIN; LATENT TRANSFORMING GROWTH FACTOR BETA 1 BINDING PROTEIN 2; LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN; PERLECAN; PROTEOHEPARAN SULFATE; SYNDECAN 4; TROPOELASTIN; UNCLASSIFIED DRUG; ACTIN BINDING PROTEIN; FBLN5 PROTEIN, HUMAN; FIBRILLIN; HEPARAN SULFATE; LTBP2 PROTEIN, HUMAN; PROTEIN BINDING; SCLEROPROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING ASSAY; BINDING SITE; BIOSYNTHESIS; CARBOXY TERMINAL SEQUENCE; CARTILAGE CELL; CONFOCAL MICROSCOPY; CONTROLLED STUDY; EAR CARTILAGE; ELASTINOGENESIS; FETUS; HUMAN; HUMAN CELL; INHIBITION KINETICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN METABOLISM; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SKIN FIBROBLAST; ANIMAL; CELL CULTURE; ELASTIC TISSUE; FIBROBLAST; GENETICS; METABOLISM; MOUSE;

ANIMALS; CELLS, CULTURED; ELASTIC TISSUE; EXTRACELLULAR MATRIX PROTEINS; FIBROBLASTS; HEPARIN; HEPARITIN SULFATE; HUMANS; LATENT TGF-BETA BINDING PROTEINS; MICE; MICROFILAMENT PROTEINS; PROTEIN BINDING; TROPOELASTIN;

EID: 84900308893     PISSN: 0945053X     EISSN: 15691802     Source Type: Journal    
DOI: 10.1016/j.matbio.2013.10.007     Document Type: Article

References (45)

1. Ali M., McKibbin M., Booth A., Parry D.A., Jain P., Riazuddin S.A., Hejtmancik J.F., Khan S.N., Firasat S., Shires M., Gilmour D.F., Towns K., Murphy A.L., Azmanov D., Tournev I., Cherninkova S., Jafri H., Raashid Y., Toomes C., Craig J., Mackey D.A., Kalaydjieva L., Riazuddin S., Inglehearn C.F. Null mutations in LTBP2 cause primary congenital glaucoma. Am. J. Hum. Genet. 2009, 84:664-671.
2. Breidthardt T., Vanpoucke G., Potocki M., Mosimann T., Ziller R., Thomas G., Laroy W., Moerman P., Socrates T., Drexler B., Mebazaa A., Kas K., Mueller C. The novel marker LTBP2 predicts all-cause and pulmonary death in patients with acute dyspnoea. Clin. Sci. (Lond.) 2012, 123:557-566.
3. Cain S.A., Baldock C., Gallagher J., Morgan A., Bax D.V., Weiss A.S., Shuttleworth C.A., Kielty C.M. Fibrillin-1 interactions with heparin. Implications for microfibril and elastic fiber assembly. J. Biol. Chem. 2005, 280:30526-30537.
4. Cain S.A., McGovern A., Baldwin A.K., Baldock C., Kielty C.M. Fibrillin-1 mutations causing weill-marchesani syndrome and acromicric and geleophysic dysplasias disrupt heparan sulfate interactions. PLoS One 2012, 7:e48634.
5. Chan S.H., Yee Ko J.M., Chan K.W., Chan Y.P., Tao Q., Hyytiainen M., Keski-Oja J., Law S., Srivastava G., Tang J., Tsao S.W., Chen H., Stanbridge E.J., Lung M.L. The ECM protein LTBP-2 is a suppressor of esophageal squamous cell carcinoma tumor formation but higher tumor expression associates with poor patient outcome. Int. J. Cancer 2011, 129:565-573.
6. Cotta-Pereira G., Guerra Rodrigo F., Bittencourt-Sampaio S. Oxytalan, elaunin, and elastic fibers in the human skin. J. Invest. Dermatol. 1976, 66:143-148.
7. Desir J., Sznajer Y., Depasse F., Roulez F., Schrooyen M., Meire F., Abramowicz M. LTBP2 null mutations in an autosomal recessive ocular syndrome with megalocornea, spherophakia, and secondary glaucoma. Eur. J. Hum. Genet. 2010, 18:761-767.
8. Doyle J.J., Gerber E.E., Dietz H.C. Matrix-dependent perturbation of TGFbeta signaling and disease. FEBS Lett. 2012, 586:2003-2015.
9. Faivre L., Gorlin R.J., Wirtz M.K., Godfrey M., Dagoneau N., Samples J.R., Le Merrer M., Collod-Beroud G., Boileau C., Munnich A., Cormier-Daire V. In frame fibrillin-1 gene deletion in autosomal dominant Weill-Marchesani syndrome. J. Med. Genet. 2003, 40:34-36.
10. Finnis M.L., Gibson M.A. Microfibril-associated glycoprotein-1 (MAGP-1) binds to the pepsin-resistant domain of the alpha3(VI) chain of type VI collagen. J. Biol. Chem. 1997, 272:22817-22823.
11. Gibson M.A., Hatzinikolas G., Davis E.C., Baker E., Sutherland G.R., Mecham R.P. Bovine latent transforming growth factor beta 1-binding protein 2: molecular cloning, identification of tissue isoforms, and immunolocalization to elastin-associated microfibrils. Mol. Cell. Biol. 1995, 15:6932-6942.
12. Haji-Seyed-Javadi R., Jelodari-Mamaghani S., Paylakhi S.H., Yazdani S., Nilforushan N., Fan J.B., Klotzle B., Mahmoudi M.J., Ebrahimian M.J., Chelich N., Taghiabadi E., Kamyab K., Boileau C., Paisan-Ruiz C., Ronaghi M., Elahi E. LTBP2 mutations cause Weill-Marchesani and Weill-Marchesani-like syndrome and affect disruptions in the extracellular matrix. Hum. Mutat. 2012, 33:1182-1187.
13. Hennink W.E., Feijen J., Ebert C.D., Kim S.W. Covalently bound conjugates of albumin and heparin: synthesis, fractionation and characterization. Thromb. Res. 1983, 29:1-13.
14. Hirai M., Horiguchi M., Ohbayashi T., Kita T., Chien K.R., Nakamura T. Latent TGF-beta-binding protein 2 binds to DANCE/fibulin-5 and regulates elastic fiber assembly. EMBO J. 2007, 26:3283-3295.
15. Hirai M., Ohbayashi T., Horiguchi M., Okawa K., Hagiwara A., Chien K.R., Kita T., Nakamura T. Fibulin-5/DANCE has an elastogenic organizer activity that is abrogated by proteolytic cleavage in vivo. J. Cell Biol. 2007, 176:1061-1071.
16. Hirani R., Hanssen E., Gibson M.A. LTBP-2 specifically interacts with the amino-terminal region of fibrillin-1 and competes with LTBP-1 for binding to this microfibrillar protein. Matrix Biol. 2007, 26:213-223.
17. Hisanaga Y., Nakashima K., Tsuruga E., Nakatomi Y., Hatakeyama Y., Ishikawa H., Sawa Y. Fibulin-5 contributes to microfibril assembly in human periodontal ligament cells. Acta Histochem. Cytochem. 2009, 42:151-157.
18. Horiguchi M., Inoue T., Ohbayashi T., Hirai M., Noda K., Marmorstein L.Y., Yabe D., Takagi K., Akama T.O., Kita T., Kimura T., Nakamura T. Fibulin-4 conducts proper elastogenesis via interaction with cross-linking enzyme lysyl oxidase. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:19029-19034.
19. Hubmacher D., Apte S.S. Genetic and functional linkage between ADAMTS superfamily proteins and fibrillin-1: a novel mechanism influencing microfibril assembly and function. Cell. Mol. Life Sci. 2011, 68:3137-3148.
20. Hyytiainen M., Penttinen C., Keski-Oja J. Latent TGF-beta binding proteins: extracellular matrix association and roles in TGF-beta activation. Crit. Rev. Clin. Lab. Sci. 2004, 41:233-264.
21. Kielty C.M. Elastic fibres in health and disease. Expert Rev. Mol. Med. 2006, 8:1-23.
22. Kielty C.M., Sherratt M.J., Marson A., Baldock C. Fibrillin microfibrils. Adv. Protein Chem. 2005, 70:405-436.
23. Kumar A., Duvvari M.R., Prabhakaran V.C., Shetty J.S., Murthy G.J., Blanton S.H. A homozygous mutation in LTBP2 causes isolated microspherophakia. Hum. Genet. 2010, 128:365-371.
24. Nakamura T., Lozano P.R., Ikeda Y., Iwanaga Y., Hinek A., Minamisawa S., Cheng C.F., Kobuke K., Dalton N., Takada Y., Tashiro K., Ross J., Honjo T., Chien K.R. Fibulin-5/DANCE is essential for elastogenesis in vivo. Nature 2002, 415:171-175.
25. Nakashima K., Tsuruga E., Hisanaga Y., Ishikawa H., Sawa Y. Stretching stimulates fibulin-5 expression and controls microfibril bundles in human periodontal ligament cells. J. Periodontal Res. 2009, 44:622-627.
26. Narooie-Nejad M., Paylakhi S.H., Shojaee S., Fazlali Z., Rezaei Kanavi M., Nilforushan N., Yazdani S., Babrzadeh F., Suri F., Ronaghi M., Elahi E., Paisan-Ruiz C. Loss of function mutations in the gene encoding latent transforming growth factor beta binding protein 2, LTBP2, cause primary congenital glaucoma. Hum. Mol. Genet. 2009, 18:3969-3977.
27. Ono R.N., Sengle G., Charbonneau N.L., Carlberg V., Bächinger H.P., Sasaki T., Lee-Arteaga S., Zilberberg L., Rifkin D.B., Ramirez F., Chu M.L., Sakai L.Y. Latent transforming growth factor beta-binding proteins and fibulins compete for fibrillin-1 and exhibit exquisite specificities in binding sites. J. Biol. Chem. 2009, 284:16872-16881.
28. Parsi M.K., Adams J.R., Whitelock J., Gibson M.A. LTBP-2 has multiple heparin/heparan sulfate binding sites. Matrix Biol. 2010, 29:393-401.
29. Perez-Magan E., Campos-Martin Y., Mur P., Fiano C., Ribalta T., Garcia J.F., Rey J.A., Rodriguez de Lope A., Mollejo M., Melendez B. Genetic alterations associated with progression and recurrence in meningiomas. J. Neuropathol. Exp. Neurol. 2012, 71:882-893.
30. Ramirez F., Dietz H.C. Marfan syndrome: from molecular pathogenesis to clinical treatment. Curr. Opin. Genet. Dev. 2007, 17:252-258.
31. Ramirez F., Rifkin D.B. Extracellular microfibrils: contextual platforms for TGFbeta and BMP signaling. Curr. Opin. Cell Biol. 2009, 21:616-622.
32. Ramirez F., Sakai L.Y. Biogenesis and function of fibrillin assemblies. Cell Tissue Res. 2010, 339:71-82.
33. Rifkin D.B. Latent transforming growth factor-beta (TGF-beta) binding proteins: orchestrators of TGF-beta availability. J. Biol. Chem. 2005, 280:7409-7412.
34. Sabatier L., Chen D., Fagotto-Kaufmann C., Hubmacher D., McKee M.D., Annis D.S., Mosher D.F., Reinhardt D.P. Fibrillin assembly requires fibronectin. Mol. Biol. Cell 2009, 20:846-858.
35. Saharinen J., Keski-Oja J. Specific sequence motif of 8-Cys repeats of TGF-beta binding proteins, LTBPs, creates a hydrophobic interaction surface for binding of small latent TGF-beta. Mol. Biol. Cell 2000, 11:2691-2704.
36. Schiemann W.P., Blobe G.C., Kalume D.E., Pandey A., Lodish H.F. Context-specific effects of fibulin-5 (DANCE/EVEC) on cell proliferation, motility, and invasion. Fibulin-5 is induced by transforming growth factor-beta and affects protein kinase cascades. J. Biol. Chem. 2002, 277:27367-27377.
37. Schlotzer-Schrehardt U., von der Mark K., Sakai L.Y., Naumann G.O. Increased extracellular deposition of fibrillin-containing fibrils in pseudoexfoliation syndrome. Invest. Ophthalmol. Vis. Sci. 1997, 38:970-984.
38. Sengle G., Tsutsui K., Keene D.R., Tufa S.F., Carlson E.J., Charbonneau N.L., Ono R.N., Sasaki T., Wirtz M.K., Samples J.R., Fessler L.I., Fessler J.H., Sekiguchi K., Hayflick S.J., Sakai L.Y. Microenvironmental regulation by fibrillin-1. PLoS Genet. 2012, 8:e1002425.
39. Shipley J.M., Mecham R.P., Maus E., Bonadio J., Rosenbloom J., McCarthy R.T., Baumann M.L., Frankfater C., Segade F., Shapiro S.D. Developmental expression of latent transforming growth factor beta binding protein 2 and its requirement early in mouse development. Mol. Cell. Biol. 2000, 20:4879-4887.
40. Tiedemann K., Batge B., Muller P.K., Reinhardt D.P. Interactions of fibrillin-1 with heparin/heparan sulfate, implications for microfibrillar assembly. J. Biol. Chem. 2001, 276:36035-36042.
41. Tsuruga E., Nakashima K., Ishikawa H., Yajima T., Sawa Y. Stretching modulates oxytalan fibers in human periodontal ligament cells. J. Periodontal Res. 2009, 44:170-174.
42. Tsuruga E., Oka K., Hatakeyama Y., Isokawa K., Sawa Y. Latent transforming growth factor-beta binding protein 2 negatively regulates coalescence of oxytalan fibers induced by stretching stress. Connect. Tissue Res. 2012, 53:521-527.
43. Vehvilainen P., Hyytiainen M., Keski-Oja J. Matrix association of latent TGF-beta binding protein-2 (LTBP-2) is dependent on fibrillin-1. J. Cell. Physiol. 2009, 221:586-593.
44. Wagenseil J.E., Mecham R.P. New insights into elastic fiber assembly. Birth Defects Res. C Embryo Today 2007, 81:229-240.
45. Zheng Q., Davis E.C., Richardson J.A., Starcher B.C., Li T., Gerard R.D., Yanagisawa H. Molecular analysis of fibulin-5 function during de novo synthesis of elastic fibers. Mol. Cell. Biol. 2007, 27:1083-1095.